"FTC Chairman Pushes Antitrust Legislation

"The chairman of the Federal Trade Commission gave some ammunition today to those who want to ban pharmaceutical companies from paying competitors who agree to delay the introduction of generic alternatives.

"Jon Leibowitz, whom President Barack Obama designated as chairman in March, said an internal FTC study has determined that eliminating such payments would save consumers $3.5 billion a year in drug costs. The so-called “exclusion payments” or “pay-for-delay payments” are the subject of several bills in Congress and of litigation in appellate courts throughout the country.

Link